Devices and methods for heart valve treatment

File for Quick & Easy Patent Protection with PowerPatent.

The Edwards Lifesciences Llc patent solves the following problem:

Various etiologies can result in heart valve lack both depending on the particular valve as well as the real cause of the disease state of the patient. For example, a congenital defect may have resulted in poor coaptation of the valve leaflets, as in the case of a monocusp aortic valve, for example. Valve also lack resulting from an infection, such as rheumatic fever, for example, causing a shame the valve leaflet. Purely regurgitation today. In such cases, the valve element may be pathologically normal, but may not work properly due to changes in the surrounding environment. Examples of such changes include the geometric change in one or more chambers of the heart and / or reduction of myocardial contractility. In any case, the consequences of volume overload that is as a result of a lack of valve to increase the chamber wall stress. Such an increase in stress may eventually result in a dilatory process of further accelerating valve dysfunction and humbled heart efficiency.

Our analysis of this patent is as follows:

Edwards Lifesciences Llc’s patent US 7666224 B2 deals with Devices and methods for heart valve treatment.
Devices and methods for improving the function of a valve (eg, mitral valve) by placing a filling device outside and adjacent to the heart wall so that the device can be used in an force against the wall of the heart valve operation. A substantially equal and opposite force to be extended to take the power of the heart wall, and / or a substantially equal and opposite to the external force used against the anatomical structure of the wall of the heart. The inner forces is enough to change the function of the valve, and increase coaptation of the leaflets, for example. The space filling device can be implanted in a surgical way, a transthoracic approach, or on a transluminal manner, for example. The space filling portion may be delivered using a delivery catheter sailed through the chosen way, and the space filling portion be expandable between a smaller configuration delivery and a greater deployment configuration.

The revolutionary TRAN&ASSOCIATES provides patent creation and management tools to help inventors protect their inventions using the patent system. Full lawyer support to complete and file the application is available.

Human resource assessment

File for Quick & Easy Patent Protection with PowerPatent.

The Data Solutions, Inc. patent solves the following problem:

Our analysis of this patent is as follows:

Data Solutions, Inc.’s patent US 7668746 B2 deals with Human resource assessment.
Methods, devices, and systems for the assessment given human resource. A resource planning device includes a processor, a memory, and a user interface with one another. devices included in the teaching program storable in memory and executable on processor to present, with a selectable configuration, organization specific human resource space after processing according to a selectable set of business rules. The selectable set of business rules process is neutral, brand neutral, and assessment neutral among the various organizations. The device can track input to specific organizations within and analyzes the input.

The revolutionary TRAN&ASSOCIATES provides patent creation and management tools to help inventors protect their inventions using the patent system. Full lawyer support to complete and file the application is available.

System and methods for endovascular aneurysm treatment

You’ve invested time, talent, and energy into making a dent in the universe with your invention and ideas. Now it’s time to make sure it’s protected with PowerPatent’s Utility, Provisional or Design Patent Filing Software

The Nellix, Inc. patent solves the following problem:

Embodiments of the present invention relates generally to medical equipment and methods for treatment. Particularly, embodiments of the present invention relates to expandable prostheses and methods for treating gastrointestinal and other aneurysm.

Our analysis of this patent is as follows:

Nellix, Inc.’s patent US 7666220 B2 deals with System and methods for endovascular aneurysm treatment.
Embodiments provide methods and systems for treating aneurysm filling structures filled with a treatment medium. A picture of a method comprises positioning at least one double-walled filling structure across the aneurysm and filling the structure (s) with a filling medium so that a wall without harmony in the aneurysm and an inner wall forms a generally tubular lumen to provide for blood. Lumen supported by a balloon or other expandable devices during and / or after the filling. The pressure within the building and / or the space between an external wall of the building and the aneurysm wall monitor and a flow of medium to the building is controlled responsive to the pressure. pressures can also be used to determine a filling endpoint. medium hardened while Lumen remained well supported. balloon is then removed by a medium.

The revolutionary TRAN&ASSOCIATES provides patent creation and management tools to help inventors protect their inventions using the patent system. Full lawyer support to complete and file the application is available.

Integrated emergency medical transportion database and virtual private network system

Patent Registration – Protect your earth-moving ideas with PowerPatent software service for Online Patent Application

The Golden Hour Data Systems, Inc. patent solves the following problem:

This invention relates to an integrated system of medical database. More specifically, this invention relates to providing a safe communication and user permission for a medical database of emergency medical transportation industry.

Our analysis of this patent is as follows:

Golden Hour Data Systems, Inc.’s patent US 7668736 B2 deals with Integrated emergency medical transportion database and virtual private network system.
A system and method for providing secure communication of data and user access authority for an integrated emergency medical transportation database. The secure communication and user authority given through a Virtual Private Network (VPN), allowing confidential patient medical records to be transmitted through a public network like the Internet without compromising the confidentiality of the data.

The revolutionary TRAN&ASSOCIATES provides patent creation and management tools to help inventors protect their inventions using the patent system. Full lawyer support to complete and file the application is available.

Flame retarded fibers and filaments and process of production therefor

Use PowerPatent’s Online Patent Filing Service to get quick patent protection for your great idea.

The Albemarle Corporation patent solves the following problem:

Although synthetic fiber materials possess a variety of excellent physical and chemical properties, a common drawback is their ready tendency to burning, so that the synthetic fiber materials traditional subjected to finish treatment for flame retardancy. Examples of finishing treatment methods include dip coating and spray coating. An obvious disadvantage of coatings is that they wear over time.

Our analysis of this patent is as follows:

Albemarle Corporation’s patent US 7666944 B2 deals with Flame retarded fibers and filaments and process of production therefor.
A fiber or filament formed from the mixture comprising (a) at least one fiber-forming thermoplastic polymer and (b) at least one polybrominated anionic styrenic polymer given. The polybrominated anionic styrenic polymer has a bromine content of at least about 50 wt%, and a GPC weight average molecular weight in the range of about 5000 to 40,000, or a GPC magnitude our average molecular weight of at least about 600,000. When the fiber-forming thermoplastic polymer is a polyester, the polybrominated anionic styrenic polymer is present in a flame resistant or flame the amount of retardant. When the fiber-forming thermoplastic polymer is a polyamide, the polybrominated anionic styrenic polymer least about 2 wt% of fibers or filaments. When the fiber-forming thermoplastic polymer is a polyolefin, at least one synergist is present, and the polybrominated anionic styrenic polymer is not greater than 15 wt% of fibers or filaments.

The revolutionary TRAN&ASSOCIATES provides patent creation and management tools to help inventors protect their inventions using the patent system. Full lawyer support to complete and file the application is available.

Nucleic acid and corresponding protein entitled 161P2F10B useful in treatment and detection of cancer

Patent Registration – Protect your earth-moving ideas with PowerPatent software service for Online Patent Application

The Agensys, Inc. patent solves the following problem:

Cancer is the second leading cause of death in human disease. Worldwide, millions of people die from cancer every year. In the United States alone, as reported by the American Cancer Society, cancer causes the death of more than a half-million people annually, with over 1.2 million new cases diagnosed per year . While death from heart disease was significantly reduced, the result in cancer in general is on the rise. In the early part of the next century, cancer is predicted to become the leading cause of death.

Our analysis of this patent is as follows:

Agensys, Inc.’s patent US 7667018 B2 deals with Nucleic acid and corresponding protein entitled 161P2F10B useful in treatment and detection of cancer.
A novel gene 0161P2F10B (also designated 161P2F10B) and the symbolic protein, and its race, described wherein 161P2F10B exhibits tissue specific expression in normal adult tissue, and aberrantly expressed in the cancers listed in Table I. Consequently, 161P2F10B gave a diagnostic, prognostic, prophylactic and / or therapeutic target for cancer. The 161P2F10B gene or fragment thereof, or the symbolic protein, or race, or a portion thereof, may be used to obtain a humoral or cellular immune response; antibody or T cells reactive with 161P2F10B can be used in active or passive immunization.

The revolutionary TRAN&ASSOCIATES provides patent creation and management tools to help inventors protect their inventions using the patent system. Full lawyer support to complete and file the application is available.

Nucleic acid and corresponding protein entitled 151P3D4 useful in treatment and detection of cancer

You’ve invested time, talent, and energy into making a dent in the universe with your invention and ideas. Now it’s time for Utility, Provisional or Design Patent Creation with PowerPatent software and services.

The Agensys, Inc. patent solves the following problem:

Cancer is the second leading cause of death in human disease. Worldwide, millions of people die from cancer every year. In the United States alone, as reported by the American Cancer Society, cancer causes the death of more than a half-million people annually, with over 1.2 million new cases diagnosed per year . While death from heart disease was significantly reduced, the result in cancer in general is on the rise. In the early part of the next century, cancer is predicted to become the leading cause of death.

Our analysis of this patent is as follows:

Agensys, Inc.’s patent US 7667015 B2 deals with Nucleic acid and corresponding protein entitled 151P3D4 useful in treatment and detection of cancer.
A novel gene (designated 151P3D4) and the symbolic protein, and dialects, which describes 151P3D4 exhibits tissue specific expression in normal adult tissue, and aberrantly expressed in the cancers listed in Table I. Consequently, 151P3D4 provides a diagnostic, prognostic, prophylactic and / or therapeutic target for cancer. The 151P3D4 gene or fragment thereof, or the symbolic protein, or race, or a portion thereof, may be used to obtain a humoral or cellular immune response; antibody or T cells reactive with 151P3D4 can be used in active or passive immunization.

The revolutionary TRAN&ASSOCIATES provides patent creation and management tools to help inventors protect their inventions using the patent system. Full lawyer support to complete and file the application is available.

Automatic gain control with out of band blocking signal compensation

File for Quick & Easy Patent Protection with PowerPatent.

The Starkey Laboratories, Inc. patent solves the following problem:

As wireless devices become more common, the potential for signal interference from the many radio sources increases. If the gain of a receiver not properly adjust for the incoming signal strength of the desired signal, the receiver would be wrong sensitive or hyper sensitive. A more sensitive receiver is likely to be a poor recipient of a lower level desired signal. A more sensitive receiver is more susceptible to noise interference. Strong signal from improper sources also increase the chance of poor reception because of over loading the front end receiver increases the chance of false signal detection.

Our analysis of this patent is as follows:

Starkey Laboratories, Inc.’s patent US 7664211 B2 deals with Automatic gain control with out of band blocking signal compensation.
A picture of this subject include a way to receive an input signal. approach, in various embodiments, includes detecting a peak of the input signal and detecting an envelope of the input signal. In various embodiments, the peak envelope and used to identify out-of-band blocking signals and adjust gain control. method also includes comparing the peak of a first opening TP and comparing the envelope into a second door Te. By the way, if the peak above the entrance and the envelope is below a second threshold, then ignore the input signal. If the envelope is on the second door, the method involves applying automatic gain control to interpret the information encoded in the input signal.

The revolutionary TRAN&ASSOCIATES provides patent creation and management tools to help inventors protect their inventions using the patent system. Full lawyer support to complete and file the application is available.

Heuristic behavior pattern matching of data flows in enhanced network traffic classification

You’ve invested time, talent, and energy into making a dent in the universe with your invention and ideas. Now it’s time to make sure it’s protected with a PowerPatent Utility, Provisional or Design Patent Application

The Packeteer, Inc. patent solves the following problem:

Economical allocation of network resources, such as available network bandwidth, has become critical as businesses increase confidence in the distributed environment Computing and wide area computer network to carry out critical tasks. The widely-used Transport Control Protocol (TCP) / Internet Protocol (IP) protocol suite, implementing world-wide data communications network environment called the Internet and used in many local area network, removing any how clear supervisory function over the rate of transport of data on various devices that make up the network. While there are certain perceived advantages, this behavior has an effect on very juxtaposing high-speed packages and very low-speed package of potential conflict and a certain lack. Some loading conditions degrade performance of networked applications and even cause weakness that can lead to overloads that stop data transfer temporarily.

Our analysis of this patent is as follows:

Packeteer, Inc.’s patent US 7664048 B1 deals with Heuristic behavior pattern matching of data flows in enhanced network traffic classification.
Methods, devices and systems to conduct enhanced traffic classification network which extends beyond the analysis of clearly presented gift packages and analyzing analyzing data flows, and some implemented, related data flowing against the known the standard application form to classify the data flowing. Implementation of the present invention facilitate the classification of encrypted or compressed traffic network, or where the higher layer data flows according to a non-public or proprietary protocol.

The revolutionary TRAN&ASSOCIATES provides patent creation and management tools to help inventors protect their inventions using the patent system. Full lawyer support to complete and file the application is available.

Missile boost-ballistic estimator

Protect your idea by filing a Provisional or Utility Patent Application with the PowerPatent Patent Service. It’s easy and fully backed by patent lawyers – and you don’t have to pay until you’re done.

The Lockheed Martin Corporation patent solves the following problem:

Modern transportation and military systems put great trust in the system of tracking flight or flying objects. In the context of transportation, air traffic control takes the place of known plane, preferably with great accuracy. US Pat. Num. 7,009,554 and 7,180,443, issued Mar. 7, 2006 and February 20, 2007, respectively, in the name of Mookerjee et al. describe the tracking system in general. In the context of the military system, there is a need to follow the arrows, the friendly and enemy, and be either unpowered (ballistic) or powered (boost). US Pat. No. 7,026,980, issued Apr. 11, 2006 on behalf of Mavroudakis et al. describes a system for identifying and tracking a target missile. A missile tracking systems described in US patent application Ser. No. 11 / 879,538, filed Jul. 18, 2007 in the name of Luu et al. describes a system that estimates the location of a missile. Luu et al. to make use of an equity holding and early thrust termination function for determining the boost or ballistic conditions, to improve the accuracy of the estimator. A system and method for tracking and to participate in an enemy missile described in US patent application Ser. No. 11 / 868,554, filed Oct. 8, 2007 in the name of Luu, et al. This system and method also tries to determine the boost or ballistic missile conditions being tracked. US patent application Ser. No. 11 / 253,309, filed October 19, 2005 on behalf of Lobo, now US Pat. No. 7,295,149, describes a system including a radar sensor, an enemy missile, an interceptor missile, a boost / ballistic determination arrangement, and an interceptor controller to use to boost , lobby / ballistic determination to help the interceptor guidance.

Our analysis of this patent is as follows:

Lockheed Martin Corporation’s patent US 7663528 B1 deals with Missile boost-ballistic estimator.
An enemy missile engager detect the missile and gives kinematic data to an interceptor missile fire control processor, foretelling the future location of the target with the help of a powered / unpowered sign. sign by the kinematic data by filtering with lags for powered and unpowered operation, the invention Salin and residual covariances. The probabilities of powered and unpowered motion determined, and thresholded. If the probability of powered mobility or unpowered motion violated his gates, the motion shall be considered known. If the target is considered to be powered, a set of three-dimensional kinematic part applied to a nine-state Kalman filter to produce an optimal state. If the target missile was unpowered, a set of three-dimensional kinematic part corresponding to the second lag applied to a six-state Kalman filter to create an optimal environment for unpowered motion. The optimal states to prevent the interceptor to the target.

The revolutionary TRAN&ASSOCIATES provides patent creation and management tools to help inventors protect their inventions using the patent system. Full lawyer support to complete and file the application is available.